Thermo Fisher Scientific Receives CE Mark for its Diagnostic Test to Detect COVID-19 WALTHAM, Mass., March 26, 2020 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced that it has received the CE mark in the European Union for its diagnostic test to detect nucleic acid from SARS-CoV-2, the... Read more
EUROIMMUN is one of the first European manufacturers of diagnostic tests to provide CE-marked antibody detection systems to support COVID-19 diagnostics. The Anti-SARS-CoV-2 ELISAs for immunoglobulin classes A and G from EUROIMMUN, a PerkinElmer, Inc. company (NYSE:PKI), have received the CE mark and can now be applied to COVID-19 diagnostics. The PCR test EURORealTime SARS-CoV-2... Read more
The Anti-SARS-CoV-2 ELISAs for immunoglobulin classes A and G from EUROIMMUN, a PerkinElmer, Inc. company (NYSE:PKI), have received the CE mark and can now be applied to COVID-19 diagnostics. The PCR test EURORealTime SARS-CoV-2 has been submitted for CE mark. COVID-19 is currently significantly affecting the lives of people worldwide. At the end of January... Read more
Italian Researchers Identify New SARS-CoV-2 Gene Variants That Provide Clues to Coronavirus’s Epidemiology Scientists say early data, generated with new NGS research panel from Thermo Fisher Scientific, suggest coronavirus is genetically stable, and could increase the effectiveness of vaccines in development CARLSBAD, Calif., March 25, 2020 /PRNewswire/ — Two teams of infectious disease researchers in Italy... Read more
WALTHAM, Mass.–(BUSINESS WIRE)–Mar. 24, 2020– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, announced today that the U.S. Food and Drug Administration (FDA) has provided Emergency Use Authorization (EUA) for the Company’s New Coronavirus RT-PCR test. Clinical laboratories certified under Clinical Laboratory Improvement Amendments (CLIA) can immediately begin using... Read more
Real-Time PCR kit validated for a variety of respiratory samples types Validated with Bruker-Hain GenoXtract 12 DNA/ RNA extraction system and kits Agreement signed with Primer Design LTD (UK), part of the Novacyt Group, for Bruker-Hain Diagnostics distribution of CE-IVD marked genesig® COVID-19 diagnostics kits NEHREN, Germany–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced a... Read more
WALTHAM, Mass., March 23, 2020 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher“) announced today that it has priced an offering of $2.2 billion aggregate principal amount (the “Offering”) of the following notes: $1.1 billion aggregate principal amount of its 4.133% senior notes due 2025, at the issue price of 100% of their principal... Read more
Thermo Fisher Scientific Continues Investments to Accelerate Biopharma Commercialization Capabilities and capacity now available to help customers of all sizes meet increasing demand for new biologics, cell and gene therapies, and drug products NEEDHAM, Mass., March 23, 2020 /PRNewswire/ — For biopharma companies faced with increasing demand for new biologics, cell and gene therapies, and drug... Read more
Danaher Receives Clearance From U.S. Federal Trade Commission For The Acquisition Of The Biopharma Business Of General Electric Life Sciences WASHINGTON, March 19, 2020 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (“Danaher”) announced today that the U.S. Federal Trade Commission (the “FTC”) has accepted the proposed consent order in connection with Danaher’s definitive agreement with General... Read more
Company Provides Update on Production Rate Read more